Cargando…
mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis
The mechanistic/mammalian target of rapamycin (mTOR) is widely implicated in the pathogenesis of various diseases, including cancer, obesity, and cardiovascular disease. Bone homeostasis is maintained by the actions of bone-resorbing osteoclasts and bone-forming osteoblasts. An imbalance in the soph...
Autores principales: | Hiraiwa, Manami, Ozaki, Kakeru, Yamada, Takanori, Iezaki, Takashi, Park, Gyujin, Fukasawa, Kazuya, Horie, Tetsuhiro, Kamada, Hikari, Tokumura, Kazuya, Motono, Mei, Kaneda, Katsuyuki, Hinoi, Eiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585391/ https://www.ncbi.nlm.nih.gov/pubmed/31263418 http://dx.doi.org/10.3389/fphar.2019.00684 |
Ejemplares similares
-
Translational Control of Sox9 RNA by mTORC1 Contributes to Skeletogenesis
por: Iezaki, Takashi, et al.
Publicado: (2018) -
ATF3 controls proliferation of osteoclast precursor and bone remodeling
por: Fukasawa, Kazuya, et al.
Publicado: (2016) -
SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability
por: Hiraiwa, Manami, et al.
Publicado: (2022) -
Hypoxia affects Slc7a5 expression through HIF‐2α in differentiated neuronal cells
por: Onishi, Yuki, et al.
Publicado: (2019) -
GDF1 is a novel mediator of macrophage infiltration in brown adipose tissue of obese mice
por: Onishi, Yuki, et al.
Publicado: (2015)